60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) COGS-to-Revenue : 0.56 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is 60 Degrees Pharmaceuticals COGS-to-Revenue?

60 Degrees Pharmaceuticals's Cost of Goods Sold for the three months ended in Mar. 2024 was $0.07 Mil. Its Revenue for the three months ended in Mar. 2024 was $0.12 Mil.

60 Degrees Pharmaceuticals's COGS to Revenue for the three months ended in Mar. 2024 was 0.56.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. 60 Degrees Pharmaceuticals's Gross Margin % for the three months ended in Mar. 2024 was 43.97%.

60 Degrees Pharmaceuticals COGS-to-Revenue Historical Data

The historical data trend for 60 Degrees Pharmaceuticals's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

60 Degrees Pharmaceuticals COGS-to-Revenue Chart

60 Degrees Pharmaceuticals Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

0.32

0.73

1.94

1.87

60 Degrees Pharmaceuticals Quarterly Data
	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial							4.29	3.07	1.39	1.17	0.56

60 Degrees Pharmaceuticals COGS-to-Revenue Calculation

60 Degrees Pharmaceuticals's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.475	/	0.254
	=	1.87

60 Degrees Pharmaceuticals's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.065	/	0.116
	=	0.56

60 Degrees Pharmaceuticals (NAS:SXTPW) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

60 Degrees Pharmaceuticals's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.065 / 0.116
	=	43.97 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

60 Degrees Pharmaceuticals COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of 60 Degrees Pharmaceuticals's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 60 Degrees Pharmaceuticals Inc (NAS:SXTPW) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

SXTP:USA

Address

1025 Connecticut Avenue NW, Suite 1000, Washington, D.C, WA, USA, 20036

Website

https://www.60degreespharma.com

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases through Arakoda and Celgosivir.